4.8 Article

Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice

Journal

JOURNAL OF HEPATOLOGY
Volume 49, Issue 3, Pages 441-450

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2008.04.026

Keywords

n-3 fatty acids; liver steatosis; SCD1; CD36; docosahexaenoic acid; sterol regulatory element-binding protein; alcohol; fatty liver; fish oil; ethanol; steatosis

Funding

  1. Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan)
  2. Japanese Ministry of Health, Labour, and Welfare
  3. Japanese Ministry of Agriculture, Forestry and Fisheries
  4. Organization for Pharmaceutical Safety and Research (OPSR, Osaka, Japan)

Ask authors/readers for more resources

Background/Aims: We examined whether dietary fish oil can prevent acute ethanol (alcohol)-induced fatty liver. Methods: Mice were fed safflower oil, fish oil, or safflower oil plus a PPAR alpha activator on the day prior to ethanol administration. Oil red O staining, serum analysis, and RT-PCR were used to analyze ethanol-induced fatty liver. Results: In mice fed safflower oil, ethanol increased liver TG 3-fold, with activation of SREBP-1c and ChREBP, which promote de novo lipogenesis, and increases in expression of mRNAs for PPAR gamma and DGATs mRNAs, which promote TG synthesis. When mice were fed fish oil, ethanol-induced fatty liver was reduced by 73%. Fish oil decreased SREBP-1c activity and increased PPARa activity. However, levels of DGAT1, DGAT2, ChREBP, LPK, and PPAR gamma mRNAs were increased in response to ethanol in mice fed fish oil. Prior administration of Wy14643, PPAR alpha activator, did not inhibit ethanol-induced fatty liver, suggesting that PPAR alpha played little role in prevention of ethanol-induced fatty liver by fish oil. Conclusions: A single dose of ethanol increases the liver TG level via several mechanisms; however, prior ingestion of fish oil effectively prevents ethanol-induced fatty liver, at least in part, by decreasing basal SREBP-1c activity, especially a marked reduction in SCD1. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available